Pepticom Announces Successful Completion of Series A1 Funding Round
Revolutionizing AI-Driven Peptide Therapeutics, Strengthening Pipeline for Next-Generation Drug Discovery JERUSALEM — January 7, 2025 — Pepticom, a pioneer in AI-driven peptide-based therapeutics, today announced the successful completion of its…